Allergen Specific Immunotherapy

13 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

770.0%

Death Rate

Active Ingredients

Allergen Specific Immunotherapy

Administration Routes

UnknownSubcutaneousSublingual

Species Affected

Dog 12

Cat 1

Most Affected Breeds

Shepherd Dog - German 5

Retriever - Labrador 2

Schnauzer - Miniature 1

Domestic Shorthair 1

Dachshund (unspecified) 1

Retriever - Golden 1

Shepherd Dog - Australian 1

Terrier - Bull - American Pit 1

Most Reported Reactions

Other abnormal test result NOS 4

Dermal mass 4

Increased borborygmus 3

Limb weakness 3

Diarrhoea 2

Decreased appetite 2

Lethargy (see also Central nervous system depression in 'Neurological') 2

INEFFECTIVE, ATOPY CONTROL 2

Underdose 2

Digestive tract disorder NOS 2

Urinary incontinence 2

Abnormal posture NOS 2

Outcome Breakdown

Ongoing

9 (69.2%)

Outcome Unknown

2 (15.4%)

Recovered/Normal

1 (7.7%)

Died

1 (7.7%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.